Lorazepam
لورازپام
🧠 Nervous SystemBenzodiazepine
Market / country: 🇺🇸 USA
Ativan (US)
🧮 Dose calculator
Anxiety and tension · Regimen source: FDA Lorazepam · Dosage and Administration
- • Usual 2–6 mg/day divided (largest at bedtime); range 1–10. Elderly: start 1–2 mg/day. FDA Lorazepam · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to benzodiazepines; acute narrow-angle glaucoma. FDA Lorazepam · Contraindications
- ⛔ Not established in children under 12. FDA Lorazepam · Pediatric Use
- ⚠️ Boxed warning: concomitant opioids (respiratory depression, death); abuse, misuse and dependence; withdrawal on abrupt stop. FDA Lorazepam · Boxed Warning
- ⛔ Injection: acute narrow-angle glaucoma, sleep apnoea, severe respiratory insufficiency (except ventilated patients), intra-arterial injection, premature infants (benzyl alcohol). FDA Lorazepam inj. · Contraindications
Formulations
- 0.5 mg tablet — tablet 🇺🇸 USA FDA Lorazepam · Dosage and Administration
- 1 mg tablet — tablet 🇺🇸 USA FDA Lorazepam · Dosage and Administration
- 2 mg tablet — tablet 🇺🇸 USA FDA Lorazepam · Dosage and Administration
- 2 mg/mL injection — injection 🇺🇸 USA FDA Lorazepam inj. · How Supplied
- 4 mg/mL injection — injection 🇺🇸 USA FDA Lorazepam inj. · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Lorazepam · Pregnancy
“Risk Summary Neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal (see WARNINGS: Neonatal Sedation and Withdrawal Syndrome and Clinical Considerations ).”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Lorazepam · Nursing Mothers
“Risk Summary Lorazepam is present in breast milk.”
- 👶 ChildrenNo data
The source for this drug has no section for this group.
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Lorazepam · Geriatric Use
“In general, dose selection for an elderly patient should be cautious, and lower doses may be sufficient in these patients (see DOSAGE AND ADMINISTRATION ).”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA078203
- DailyMed (FDA label)FDA LorazepamFDA Lorazepam inj.
- MedlinePlus (NIH)Lorazepam
- WHO ATC/DDDN05BA06
- Darooyab (Iran)Lorazepam
🇮🇷 Registered in Iran Darooyab · G-1295/Lorazepam
Dosage forms with Iranian generic codes, per Darooyab.
- 00771 · LORAZEPAM 1MG TAB · قرص لورازپام ۱ میلیگرم
- 00772 · LORAZEPAM 2MG TAB · قرص لورازپام ۲ میلیگرم
- 01575 · LORAZEPAM 2MG/ML AMP · آمپول لورازپام ۲ میلیگرم / میلیلیتر
- 01576 · LORAZEPAM 4MG/ML AMP · آمپول لورازپام ۴ میلیگرم / میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Lorazepam · Dosage and AdministrationFDA Lorazepam inj. · How SuppliedFDA Lorazepam inj. · Dosage and Administration — Status EpilepticusFDA Lorazepam · ContraindicationsFDA Lorazepam · Pediatric UseFDA Lorazepam · Boxed WarningFDA Lorazepam inj. · ContraindicationsFDA Lorazepam · PregnancyFDA Lorazepam · Nursing MothersFDA Lorazepam · Geriatric UseFDA Lorazepam · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1295/Lorazepam
- Clinical review⚠ Unverified